-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
HCW Biologics Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q3 2024.
- HCW Biologics Inc. Cost of Revenue for the quarter ending September 30, 2024 was $341K, a 49.7% decline year-over-year.
- HCW Biologics Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $2.36M, a 3.49% increase year-over-year.
- HCW Biologics Inc. annual Cost of Revenue for 2023 was $2.28M, a 44.8% decline from 2022.
- HCW Biologics Inc. annual Cost of Revenue for 2022 was $4.14M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)